What is the current hematocrit tests market size?

The hematocrit tests market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the hematocrit tests market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the hematocrit tests market?

Increasing demand for blood tests and advancements in technology are key drivers.

What are the major challenges facing the hematocrit tests market?

High costs and limited accessibility in developing regions are major challenges.

Which regions are leading the hematocrit tests market?

North America and Europe are leading the market due to high demand.

Who are the top companies in the hematocrit tests market?

Top companies include Abbott Laboratories and Siemens Healthcare.

What future opportunities exist in the hematocrit tests market?

Emerging markets and technological advancements offer future opportunities.

How is technology impacting the hematocrit tests market?

Technological advancements are improving test accuracy and efficiency.

What is the current regulatory landscape for the hematocrit tests market?

The market is regulated by agencies such as the FDA and CE Mark.

What is the future outlook for the hematocrit tests market?

The market is expected to grow due to increasing demand for blood tests.

hematocrit tests Market Intelligence Report 2026 — Updated June 2026

hematocrit tests by Application (Hospital, Diagnostic Center, Specialist Clinic, Hospital Pharmacy), by Types (Analyzer, Hematocrit Test Meters) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

hematocrit tests Market Overview

The hematocrit tests market refers to the industry involved in the development and distribution of tests used to measure the proportion of red blood cells in the blood. As a crucial component of blood tests, the hematocrit tests market size is significant, with an estimated global value of approximately $1.4 billion in 2025. The growth outlook for this market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of around 5-7% during the forecast period from 2026 to 2033. This industry expansion can be attributed to various macro drivers, including an increasing prevalence of blood-related disorders and a growing demand for diagnostic tests. The scope of the hematocrit tests market encompasses various types of tests, including manual and automated tests, and applications in hospitals, clinics, and research institutions.

Loading chart…

Key forces shaping the hematocrit tests market include technology shifts, such as the development of automated and point-of-care tests, regulations that govern the use of diagnostic tests, and changes in consumer behavior, such as an increasing awareness of the importance of blood tests. The largest region in the hematocrit tests market is North America, while the fastest-growing region is Asia Pacific. Overall, the hematocrit tests market is expected to experience significant growth in the coming years, driven by increasing demand for diagnostic tests and the development of new technologies.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	18.23 million
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Abbott; Roche; Danaher; Bio-Rad; Horiba; Siemens; Nihon Kohden; Mindray Medical; Boule Diagnostics; Sysmex; Nova Biomedical; EKF Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The hematocrit tests market is experiencing significant growth due to various factors. The market dynamics are influenced by several key drivers, restraints, opportunities, and challenges that impact the hematocrit tests market size and growth forecast.

Growth Drivers2 items

Increasing demand for point-of-care diagnostics is driving the adoption of hematocrit tests, particularly in remote or resource-limited areas where laboratory facilities are scarce.

Advancements in microfluidics technology have enabled the development of portable, user-friendly, and cost-effective hematocrit testing devices, expanding their accessibility and appeal to a broader range of users.

Restraints2 items

Stringent regulatory requirements and the need for FDA clearance can hinder the introduction of new hematocrit testing products, particularly for smaller manufacturers or startups with limited resources.

The high cost of advanced hematocrit testing equipment can be a significant barrier to adoption, especially in low- and middle-income countries where healthcare budgets are constrained.

Opportunities2 items

The growing telehealth market presents opportunities for hematocrit test manufacturers to develop remote monitoring solutions that integrate with existing telehealth platforms, enhancing patient care and outcomes.

The increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, is driving demand for hematocrit tests as a vital component of disease management and monitoring.

Challenges2 items

The hematocrit tests market is highly competitive, with numerous established players and new entrants, making it challenging for companies to differentiate their products and maintain market share.

Ensuring data accuracy and reliability is a significant challenge in hematocrit testing, particularly in point-of-care settings where testing conditions may vary and user expertise may be limited.

Market Segmentation

Loading chart…

The hematocrit tests market can be segmented based on application, which refers to the various uses of hematocrit tests in medical diagnosis and research. Hematocrit tests segmentation is a crucial aspect of market taxonomy, as it helps to identify the different areas where these tests are applied, contributing to the overall market size. The application segment includes diagnosis of diseases such as anemia, blood disorders, and other conditions where blood cell count is crucial.

Another significant segmentation category in the hematocrit tests market is types, which encompasses various subtypes such as manual and automated hematocrit tests. Each subtype has its own set of applications, advantages, and limitations, influencing the overall market dynamics. For instance, automated hematocrit tests are widely used in clinical settings due to their high accuracy and efficiency, while manual tests are often used in research and development. Understanding these subtypes is essential for analyzing the market size and growth prospects of the hematocrit tests market.

hematocrit tests Segmentation Breakdown8 items

Application

Hospital

Diagnostic Center

Specialist Clinic

Hospital Pharmacy

Types

Analyzer

Hematocrit Test Meters

Regional Insights

Loading chart…

The hematocrit tests market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of hematocrit tests, government policies supporting healthcare infrastructure development, and significant investments in the healthcare sector.

Key drivers for each region include: North America, driven by established infrastructure and ecosystem maturity; Europe, fueled by demographics and policies supporting healthcare access; Asia Pacific, driven by adoption and investments; Latin America, influenced by policies and infrastructure development; and Middle East & Africa, impacted by demographics and investments.

The regional forecast indicates that the hematocrit tests market will experience significant growth, with Asia Pacific expected to drive the market growth due to its large and growing population, increasing adoption of hematocrit tests, and rising healthcare expenditure. The regional dynamics will play a crucial role in shaping the hematocrit tests market growth in the coming years.

Competitive Landscape

The hematocrit tests market is moderately consolidated, driven by a mix of global players and local companies. The hematocrit tests competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on expanding their product portfolios and strengthening their distribution networks, while local companies concentrate on regional expansion and customization to meet specific customer needs.

Companies in the hematocrit tests market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Key differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on innovation, customer satisfaction, and operational efficiency.

Abbott: regional expansion

Roche: premium pricing

Danaher: innovation pipeline

Bio-Rad: OEM tie-ups

Horiba: local manufacturing

Siemens: vertical integration

Key hematocrit tests Companies12 items

Abbott

Roche

Danaher

Bio-Rad

Horiba

Siemens

Nihon Kohden

Mindray Medical

Boule Diagnostics

Sysmex

Nova Biomedical

EKF Diagnostics

Market Ecosystem

The hematocrit tests ecosystem encompasses a broad range of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be divided into three main segments: upstream, midstream, and downstream. Upstream participants, such as raw material suppliers and technology providers, create and supply the foundational components and technologies used in hematocrit tests. Midstream participants, including manufacturers and system integrators, assemble and integrate these components into finished products. Downstream participants, comprising distributors, service providers, and end users, facilitate the delivery and use of these products.

Ecosystem Participants7 items

Raw material/component suppliers — provide critical components

OEMs / manufacturers — produce hematocrit testing equipment

Technology providers — develop underlying technologies

System integrators / EPCs — integrate systems and equipment

Distributors / channel partners — facilitate product delivery

Service providers / after-sales — offer maintenance and support

End users / buyers — purchase and utilize hematocrit tests

Within the hematocrit tests ecosystem, value flows through the creation and capture of innovative products and services. Control points, such as regulatory approvals and standards, influence the adoption of hematocrit tests. Dependency risks, including input constraints and technological advancements, can impact the ecosystem's efficiency. Switching costs and interoperability requirements also affect partnerships and collaborations among participants. A thorough value chain analysis of the hematocrit tests ecosystem is necessary to understand these complex interactions and identify potential bottlenecks.

Recent Industry Insights

The hematocrit tests industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as the collaboration between leading diagnostic companies to enhance point-of-care testing, have been formed to improve the accessibility and accuracy of hematocrit tests. Additionally, there have been key mergers and acquisitions, including the takeover of a prominent hematocrit testing device manufacturer by a major healthcare company, which is expected to expand the product portfolio and global reach.

Furthermore, several product launches have taken place, introducing innovative, portable, and user-friendly hematocrit testing devices. Regulatory changes, such as the updated guidelines for hematocrit testing in clinical settings, have also been observed. The hematocrit tests industry has seen a shift in consumer trends, with an increasing demand for at-home testing kits, driving companies to focus on developing convenient and cost-effective solutions. Funding rounds have been secured by emerging companies to support the development of cutting-edge hematocrit testing technologies, further propelling the growth of the hematocrit tests industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the hematocrit tests market. The market attractiveness is driven by increasing demand for point-of-care diagnostics and advancements in technology. The competitive intensity is moderate, with key players focusing on innovation and expansion into emerging markets. The long-term outlook for the hematocrit tests market outlook is positive, with a growing need for accurate and efficient diagnostic tests. However, the demand-supply balance may be affected by regulatory changes and supply chain disruptions. Key risk factors include intense competition and rapid technological changes, which may impact market growth.

11 items

1. Executive Summary

2. hematocrit tests Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global hematocrit tests Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global hematocrit tests Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Diagnostic Center

6.1.3. Specialist Clinic

6.1.4. Hospital Pharmacy

6.2. Global hematocrit tests Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Analyzer

6.2.2. Hematocrit Test Meters

6.3. Global hematocrit tests Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global hematocrit tests Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global hematocrit tests Market by: Regions (Value)

8. Global hematocrit tests Market Competition by Key Manufacturers

8.1. Global hematocrit tests Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global hematocrit tests: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Roche

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Danaher

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bio-Rad

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Horiba

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Siemens

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Nihon Kohden

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mindray Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Boule Diagnostics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Sysmex

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Nova Biomedical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. EKF Diagnostics

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global hematocrit tests Market

Figure 4: Global hematocrit tests Market: Drivers

Figure 5: Global hematocrit tests Market: Challenges

Figure 6: Global hematocrit tests Market: Trends

Figure 7: Global hematocrit tests Market: Opportunity

Figure 8: Global hematocrit tests Market: Restraint

Figure 9: Global hematocrit tests Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global hematocrit tests Market Value (USD Million) By Region

Figure 15: Global hematocrit tests Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global hematocrit tests Market Value (USD Million) By Region

Figure 23: Global hematocrit tests Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global hematocrit tests Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global hematocrit tests Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global hematocrit tests Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global hematocrit tests Market Value (USD Million) By Region

Table 10: Global hematocrit tests Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global hematocrit tests Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global hematocrit tests Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global hematocrit tests Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Roche Basic Information And Sales Area

Table 33: Roche. Products Portfolio

Table 34: Danaher Basic Information And Sales Area

Table 35: Danaher. Products Portfolio

Table 36: Bio-Rad Basic Information And Sales Area

Table 37: Bio-Rad. Products Portfolio

Table 38: Horiba Basic Information And Sales Area

Table 39: Horiba. Products Portfolio

Table 40: Siemens Basic Information And Sales Area

Table 41: Siemens. Products Portfolio

Table 42: Nihon Kohden Basic Information And Sales Area

Table 43: Nihon Kohden. Products Portfolio

Table 44: Mindray Medical Basic Information And Sales Area

Table 45: Mindray Medical. Products Portfolio

Table 46: Boule Diagnostics Basic Information And Sales Area

Table 47: Boule Diagnostics. Products Portfolio

Table 48: Sysmex Basic Information And Sales Area

Table 49: Sysmex. Products Portfolio

Table 50: Nova Biomedical Basic Information And Sales Area

Table 51: Nova Biomedical. Products Portfolio

Table 52: EKF Diagnostics Basic Information And Sales Area

Table 53: EKF Diagnostics. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global hematocrit tests Market Value (USD Million) By Region

Table 59: Global hematocrit tests Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

hematocrit tests Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	18.23 million
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Abbott; Roche; Danaher; Bio-Rad; Horiba; Siemens; Nihon Kohden; Mindray Medical; Boule Diagnostics; Sysmex; Nova Biomedical; EKF Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for point-of-care diagnostics is driving the adoption of hematocrit tests, particularly in remote or resource-limited areas where laboratory facilities are scarce.

Restraints2 items

The high cost of advanced hematocrit testing equipment can be a significant barrier to adoption, especially in low- and middle-income countries where healthcare budgets are constrained.

Opportunities2 items

The increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, is driving demand for hematocrit tests as a vital component of disease management and monitoring.

Challenges2 items

Market Segmentation

Loading chart…

hematocrit tests Segmentation Breakdown8 items

Application

Hospital

Diagnostic Center

Specialist Clinic

Hospital Pharmacy

Types

Analyzer

Hematocrit Test Meters

Regional Insights

Loading chart…

Competitive Landscape

Abbott: regional expansion

Roche: premium pricing

Danaher: innovation pipeline

Bio-Rad: OEM tie-ups

Horiba: local manufacturing

Siemens: vertical integration

Key hematocrit tests Companies12 items

Abbott

Roche

Danaher

Bio-Rad

Horiba

Siemens

Nihon Kohden

Mindray Medical

Boule Diagnostics

Sysmex

Nova Biomedical

EKF Diagnostics

Market Ecosystem

Ecosystem Participants7 items

Raw material/component suppliers — provide critical components

OEMs / manufacturers — produce hematocrit testing equipment

Technology providers — develop underlying technologies

System integrators / EPCs — integrate systems and equipment

Distributors / channel partners — facilitate product delivery

Service providers / after-sales — offer maintenance and support

End users / buyers — purchase and utilize hematocrit tests

Recent Industry Insights

Analyst Overview

Table of Contents